Literature DB >> 16809335

Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42.

R Jiang1, R S Scott, L M Hutt-Fletcher.   

Abstract

Epstein-Barr virus is an orally transmitted human herpesvirus that infects epithelial cells and establishes latency in memory B lymphocytes. Movement of virus between the two cell types is facilitated by changes in amounts of an envelope glycoprotein, gp42, which are effected by interaction of gp42 with HLA class II in a B cell. Here we used the differential ability of virus to bind to CD21-positive B cells and CD21-negative epithelial cells, which is also influenced by levels of gp42, to determine that the majority of virus shed in saliva is derived from an HLA class II-negative cell.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809335      PMCID: PMC1489022          DOI: 10.1128/JVI.00497-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.

Authors:  K M Haan; W W Kwok; R Longnecker; P Speck
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus.

Authors:  Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

3.  Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells.

Authors:  T Oda; S Imai; S Chiba; K Takada
Journal:  Virology       Date:  2000-10-10       Impact factor: 3.616

4.  Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein-Barr virus-induced membrane fusion.

Authors:  K M Haan; S K Lee; R Longnecker
Journal:  Virology       Date:  2001-11-10       Impact factor: 3.616

5.  Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infection.

Authors:  K M Haan; R Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  Epstein-Barr virus that lacks glycoprotein gN is impaired in assembly and infection.

Authors:  C M Lake; L M Hutt-Fletcher
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells.

Authors:  Sharof M Tugizov; Jennifer W Berline; Joel M Palefsky
Journal:  Nat Med       Date:  2003-02-18       Impact factor: 53.440

8.  A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease.

Authors:  Yan-Jun Gan; Bassem I Razzouk; Tao Su; John W Sixbey
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

9.  Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells.

Authors:  X Wang; W J Kenyon; Q Li; J Müllberg; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection.

Authors:  Corina M Borza; Andrew J Morgan; Susan M Turk; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more
  33 in total

1.  Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals.

Authors:  Giao T Huynh; Libin Rong
Journal:  J Theor Biol       Date:  2012-06-07       Impact factor: 2.691

Review 2.  Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection.

Authors:  Lindsey M Hutt-Fletcher; Liudmila S Chesnokova
Journal:  Virulence       Date:  2010 Sep-Oct       Impact factor: 5.882

3.  Fusion of Epstein-Barr virus with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8, and integrin binding triggers a conformational change in glycoproteins gHgL.

Authors:  Liudmila S Chesnokova; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.

Authors:  Zhen Lin; Kenneth Swan; Xin Zhang; Subing Cao; Zoe Brett; Stacy Drury; Michael J Strong; Claire Fewell; Adriane Puetter; Xia Wang; MaryBeth Ferris; Deborah E Sullivan; Li Li; Erik K Flemington
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

5.  Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells.

Authors:  Susan M Turk; Ru Jiang; Liudmila S Chesnokova; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 6.  Epstein-Barr virus entry.

Authors:  Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

7.  Epstein-Barr virus transcytosis through polarized oral epithelial cells.

Authors:  Sharof M Tugizov; Rossana Herrera; Joel M Palefsky
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

Review 8.  Epstein-Barr virus in the pathogenesis of oral cancers.

Authors:  J T Guidry; C E Birdwell; R S Scott
Journal:  Oral Dis       Date:  2017-04-18       Impact factor: 3.511

9.  Efficient replication of Epstein-Barr virus in stratified epithelium in vitro.

Authors:  Rachel M Temple; Junjia Zhu; Lynn Budgeon; Neil David Christensen; Craig Meyers; Clare E Sample
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

10.  The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output.

Authors:  Vey Hadinoto; Michael Shapiro; Chia Chi Sun; David A Thorley-Lawson
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.